baber/WOPTO huggingface dataset:
Patent NZ-542368-A (NZ)
Title: Door guard
Inventor: CUFFE DAVID
Filed: 2005-09-14
Abstract: Described is a guard for use with a door, the door being of a kind which has a peripheral frame that defines a generally square or rectangular interior. The door has a mesh screen extending across the interior and is connected to the frame; a latch assembly which includes a bolt and which is operable by actuator means to move between extended and retracted positions, wherein the guard has a body which in use is positioned to overlie a portion of the screen in the vicinity of the latch assembly to hinder access to the actuator means from a side of the screen opposite the guard, and wherein a portion of the body extends in a direction which is transverse to the general plane of the screen.
Patent NZ-543480-A (NZ)
Title: Wash plate for an automatic clothes washer
Inventor: LABELLE KATHLEEN M
Filed: 2005-11-09
Abstract: An automatic washing machine comprises a wash tub and a wash plate movably mounted within the wash tub for imparting mechanical energy to articles of fabric in the wash tub. The wash plate comprises a base and a blade that extends from the base and terminates in a tip. According to the invention, at least the tip of the blade is formed by an insert. The insert is made from a relatively hard and wear resistant material that is different than the material of the impeller body. As a result, the wear resistance and performance of the impeller is improved without significantly increasing the overall cost of the impeller.
Patent NZ-545339-A (NZ)
Title: Process for preparation of flax protein isolate
Inventor: GREEN BRENT E
IPC: A23J3/14
Filed: 2004-07-30
Abstract: Flax protein isolates are obtained in a procedure in which flax oil seeds are initially extracted to remove mucilage therefrom prior to crushing to recover the oil and produce a meal. The flax protein meal then is processed to recover a flax protein isolate therefrom, wherein the initial extraction of the flax seed at elevated temperature using a mildly-alkaline solution of sodium bicarbonate to remove mucilage results in the production of a much higher concentration of concentrated aqueous protein solution, enabling improved yields of flax protein isolate to be obtained. In addition, a flax protein isolate can be produced from flax protein meal by isoelectric precipitation or by a micellar route.
Patent NZ-545371-A (NZ)
Title: Improvements in or relating to stock ramps
Inventor: MURRAY DARYN LLOYD
Filed: 2006-02-15
Abstract: A stock ramp is disclosed. The stock ramp has first and second elongate sidewalls extending substantially parallel to one another, spaced apart by an elongate runway, wherein: a. the runway is operable between a first position, at which the runway is configured and arranged to enable animals to pass along its length between the first and second sidewalls, and a second position, at which the runway is pivoted up against the first sidewall; b. the first sidewall is hingedly connected along its length to the runway to enable the runway to pivot up and fold substantially flat against the first sidewall, when in the second position; and c. at least two runway support means that extend between and connect the first and second sidewalls and support the runway when in the first position, each the runway support means having a first end pivotally connected to the first sidewall and a second end pivotally connected to the second sidewall, such that the sidewalls are able to move between a first position where the sidewalls are held at maximum spacing in fixed parallel relationship by the runway, and a second position where the runway is folded up against the first sidewall, and the runway support means are pivoted to collapse the second sidewall longitudinally against the runway and first sidewall.
Patent NZ-545656-A (NZ)
Title: AAV vectors for in vivo gene therapy of rheumatoid arthritis
Inventor: TAK PAUL PETER
Filed: 2004-09-01
Abstract: Disclosed is a method for delivering a nucleic acid molecule to a rheumatoid synovial cells in vivo, the method comprising the steps of (a) providing a recombinant AAV virion (rAAV) comprising capsid proteins of AAV serotype 5 or AAV serotype 2, wherein the rAAV virion comprises a rAAVX vector, the rAAVX vector comprising an expression element operably linked to a nucleic acid sequence; and, (b) bringing the rAAV virion into contact with the synovial cell, whereby transduction of the rAAVX vector results in expression of the nucleic acid sequence in the transduced synovial cells.
Patent NZ-550540-A (NZ)
Title: Exercise and amusement apparatus
Inventor: FILLEUL DENYS LLOYD
Filed: 2006-10-16
Abstract: An amusement apparatus is disclosed for traversing along a monorail by a suspended user rotating crank handles which drive drive wheels engageable with a surface of the monorail. A belt drive arrangement may be used to couple the crank handles to the drive wheels. The user may be suspended by holding onto the crank handles or by way of a seat suspended from the apparatus. The monorail may be of rectangular cross section with an upright longitudinal flange.
Patent NZ-554118-A (NZ)
Title: Microphone for a communications apparatus
Inventor: MIRANDA STEPHEN ALFRED
IPC: H04B1/38
Filed: 2003-09-05
Abstract: A vibration conduction microphone includes a housing in which a transducer is positioned. An acoustic isolator is also positioned in the housing, the acoustic isolator being disposed about the transducer. Preferably the acoustic isolator includes a holder for a visco-elastic material.
Patent NZ-563315-A (NZ)
Title: A device that can be used for bracing the pelvic region of a patient
Inventor: RICHARDSON MARTIN
IPC: A61F5/01
Filed: 2006-05-02
Abstract: A device that can be used for bracing the pelvic region of a patient is disclosed. The device includes a plurality of bracing elements. One or more of the bracing elements include first and second straps and an attachment means. The first strap is detachably connected to the second strap at a first point of interconnection. The interconnection can be moved along the second strap so that the combined length of the first and second straps can be altered. This alteration allows adjustment of the length of the bracing element that can be wrapped at least in part around or about the pelvic region of a patient. The attachment means, in use, can detachably interconnect the second strap directly or indirectly to the first strap so that the bracing element forms a closed loop that can at least partially be wrapped around or about the patient. The attachment means detachably interconnects the first and second straps at a second point of interconnection. The second interconnection can be moved along the first strap to further adjust the length of the bracing element can be wrapped at least in part around the pelvic region of a patient.
Patent NZ-569704-A (NZ)
Title: Oil formulations, comprising cyclopropene, for treating plants
Inventor: KOSTANSEK EDWARD CHARLES
IPC: A01G7/06
Filed: 2008-07-09
Abstract: Disclosed is a composition comprising an oil medium, wherein solid particles are suspended in said oil medium, wherein said solid particles comprise cyclopropene and molecular encapsulating agent that encapsulates said cyclopropene or a portion of said cyclopropene, and wherein said solid particles have median size, as measured by the largest dimension, of 50 micrometer or less, wherein said cyclopropene is any compound with the formula (I) wherein the substituents are disclosed within the specification; wherein said oil is a compound that is liquid at 25 degrees Celsius and one atmosphere pressure; that has boiling point at one atmosphere pressure of 30 degrees Celsius or higher; and that is not water, surfactant, or dispersant; and wherein said oil medium is in the form of droplets suspended in water. Also disclosed is a process for forming a composition, said process comprising making a mixture comprising putting cyclopropene complex in which a molecular encapsulating agent encapsulates one or more cyclopropene or a portion of one or more cyclopropene, oil, and dispersant into a media mill; and milling said mixture to form solid particles that comprise said cyclopropene complex, wherein said solid particles have median size, as measured by the longest length, of 50 micrometer or less, wherein said cyclopropene is a compound of formula (I) wherein the substituents are disclosed within the specification; wherein said oil is a compound that is liquid at 25 degrees Celsius and one atmosphere pressure; that has boiling point at one atmosphere pressure of 30 degrees or higher; and that is not water, surfactant, or dispersant.
Patent NZ-571080-A (NZ)
Title: Gas sensor that measures gas levels by the absorption of reflected radiation
Inventor: SMITH MICHAEL J
IPC: G01N21/35
Filed: 2007-02-06
Abstract: A gas sensor comprises a radiation source 2, a radiation detector 3, and a reflecting means 5 arranged to reflect radiation from the radiation source 2 to the radiation detector 3 along an optical path. The radiation source 2 and the radiation detector 3 are disposed side by side. The reflecting means 5 comprises a surface with a plurality of sub surfaces 6. Each sub surface 6 is defined by an arc with a radius and a centre point, the arcs being swept out around an axis. The arc of each sub surface 6 has a different radius and a different centre point from that of an adjacent sub surface.
Patent NZ-572108-A (NZ)
Title: Bio-stimulant nitrogen response enhancer for improved plant growth
Inventor: JENKINS TIMOTHY ALLEN
IPC: A01N63/00
Filed: 2008-10-20
Abstract: Provided is a composition for improving plant growth or plant development comprising a fermentation broth formulated for foliar application, wherein the fermentation broth comprises a mixture of cellular components from one or more strains of bacteria and one or more strains of yeast which have been grown in a broth to a range of about 106 to about 1010 cfu/ml and then lysed in the broth. The bacteria may be Lactobacillus, Streptococcus or Propionibacter.
Patent NZ-578914-A (NZ)
Title: Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof
Inventor: SHIH CHARLES C
IPC: A61P29/00
Filed: 2008-01-08
Abstract: Disclosed are pharmaceutical compositions comprising a curcumin derivative compound of formula (IIa) or (IIb) for treating a subject suffering from an androgen receptor associated medical condition such as acne, inflammation and cancer.
Patent NZ-585913-A (NZ)
Title: Formulations and tablets comprising (6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino)-2,2-dimethyl-3-oxo-2H-pyrido[3,2-b][1,4]oxazin-4(3H)-yl)methyl phosphate (fostamatinib) disodium salt
Inventor: SUN THOMAS
IPC: A61K9/20
Filed: 2008-11-06
Abstract: Disclosed are formulations (such as those obtained by wet granulation) which comprise: (a) fostamatinib disodium salt (i.e. the disodium salt of 6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino)-2,2-dimethyl-3-oxo-2H-pyrido[3,2-b][1,4]oxazin-4(3H)-yl)methyl phosphate); (b) water; (c) a water sequestering agent which inhibits the decomposition of fostamatinib disodium, and which is preferably selected from the group consisting of starch (especially pregelatinized starch), magnesium sulfate, calcium chloride, silica gel, or kaolin; and optionally at least one filler, lubricant, suspending/dispersing agent, binding agent, or a disintegrant. Further disclosed is a method for formulating fostamatinib disodium into a formulation for tablet compression which comprises: a) blending fostamatinib disodium with starch and optionally at least one of filler, lubricant, suspending/dispersing agent, binding agent or disintegrant, at an impeller speed sufficient to form a homogenous powder mixture having a bulk density after drying of about 6 kp to about 30 kp; b) spraying between about 15 percent and about 40 percent by weight of water into the homogenous powder mixture of a) and mixing to form enlarged granules; and c) drying the enlarged granules of b) until between about 5% and about 11% of water is lost on drying to provide dried granules.
Patent NZ-588259-A (NZ)
Title: Bioavailable solid dosage forms of metaxalone and processes for producing the same
Inventor: SPIREAS SPIRIDON
IPC: A61K9/42
Filed: 2005-03-08
Abstract: Disclosed is pharmaceutical solid dosage form comprising an effective amount of metaxalone, at least one inactive powder excipient selected from a group comprising sparingly water-soluble or essentially water-insoluble, natural or synthetic hydrocolloids and polymers, and optionally at least one nonvolatile liquid, prepared by the method comprising the steps of: i. providing an effective amount of metaxalone; ii. providing at least one inactive powder excipient selected from a group comprising natural or synthetic hydrocolloids and polymers; iii. blending the effective amount of metaxalone and the at least one inactive powder excipient; iv. wetting the blend with at least one volatile liquid and optionally at least one non-volatile liquid to form a mix; v. granulating the mix to form a granulation; vi. drying and milling the granulation; vii. mixing with at least one inactive powder excipient; and viii. compressing into a solid dosage form, wherein said dosage form presents improved drug dissolution rate as compared to the metaxalone product of NDA #13-217 (Trade name: Skelaxin). The metaxalone dosage is useful for treating a musculoskeletal condition.
Patent NZ-589845-A (NZ)
Title: Flexible structure for mask having a flexible gel filled structure including two gells of diferent hardness
Inventor: CARROLL FIONA CATHERINE
IPC: A61M16/06
Filed: 2009-05-29
Abstract: 589845 A respiratory mask (10) is disclosed comprising a frame (40) and a flexible structure (20) adapted to engage a patient's face. The flexible structure (20) including a chamber filled with a first gel (G1) and a second gel (G2) that is relatively harder than the first gel. The ratio of height of the first gel to the second gel is between 0.25 and 0.6 and the interface between the gel layers forms a hinge point to control buckling and/or bending of the mask in use.
Patent NZ-593276-A (NZ)
Title: A light distribution system
Inventor: PULLIKASERIL CIBBY B
IPC: F21S11/00
Filed: 2009-11-09
Abstract: 593276 A light distribution system comprising a plurality of light converging elements 10 for concentrating light 11, and a plurality of wavelength selective optical conduits 12 each being operatively coupled to respective of the light converging elements 10, and configured to receive converged light from the respective light converging element 10 and transport at least a portion of the converged light in the wavelength selective optical conduits 12, and a light dispersing module 16 operatively coupled to the plurality of wavelength selective optical conduits 12 for dispersing light transported in the optical conduits 12.
Patent NZ-594309-A (NZ)
Title: Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
Inventor: GIJSEN HENRICUS JACOBUS MARIA
IPC: C07D401/14
Filed: 2010-02-15
Abstract: Disclosed herein are substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives of formula (I) for use in the treatment of diseases and disorders which benefit from the modulation of gamma-secretase activity, such as Alzheimer's disease, traumatic brain injury, mild cognitive impairment, senility, dementia, dementia with Lewy bodies, cerebral amyloid angiopathy, multi- infarct dementia, Down's syndrome, dementia associated with Parkinson's disease and dementia associated with beta-amyloid. In a preferred embodiment of the invention, formula (I) may represent: N-[3-fluoro-4-(4-methyl-1H-imidazol-1-yl)phenyl]-2-(4-fluorophenyl)-1,6-dimethyl-1H-imidazo[4,5-c]pyridin-4-amine; 2-(4-fluorophenyl)-N-[6-methoxy-5-(4-methyl-1H-imidazol-1-yl)-2-pyridinyl]-1-methyl-1H-benzimidazol-4-amine; 2-(2,3-difluorophenyl)-N-[6-methoxy-5-(4-methyl-1H-imidazol-1-yl)-2-pyridinyl]-1-methyl-1-1H -benzimidazol-4-amine; 2-(4-fluoro-3-methoxyphenyl)-N-[6-methoxy-5-(4-methyl-1H-imidazol-1-yl)-2-pyridinyl]-1-methyl-1H-benzimidazol-4-amine; or 2-(3,5-dimethoxyphenyl)-N-[6-methoxy-5-(4-methyl-1H-imidazol-1-yl)-2-pyridinyl]-1-methyl-1H -benzimidazol-4-amine.
Patent NZ-598270-A (NZ)
Title: Dhea compositions for treating menopause
Inventor: LABRIE FERNAND
IPC: A61K31/453
Filed: 2008-08-08
Abstract: ABSTRACT - 598270 Disclosed herein is a use of a sex steroid precursor selected from the group consisting of dehydroepiandrosterone, dehydroepiandrosterone-sulfate, androst-5-ene-3?,17?-diol, and 4-androsten-3,17-dione in the manufacture of a medicament for treating and/or reducing the likelihood of acquiring symptoms or diseases due to the menopause, in postmenopausal women, wherein the symptoms or diseases due to the menopause are selected from the group of diseases consisting of Osteoporosis, vaginal atrophy, vulvo-vaginal dryness, hypogonadism, diminished libido, skin atrophy, connective tissue disease, urinary incontinence, breast, endometrial, ovarian and uterine cancers, hot flashes, loss of muscle mass, insulin resistance, fatigue, loss of energy, aging, and physical symptoms and signs of menopause, wherein said medicament is formulated for administration of the sex steroid precursor to a patient in need of said treatment at a therapeutic amount which increases the level of circulating androgen metabolites, namely, androsterone glucuronide (ADT-G), androstane-3(,17(-diol-3-glucuronide (3(-diol-3G), and androstane-3(,17(-diol-17-glucuronide (3(-diol-17G), as part of a combination therapy with a therapeutically effective amount of a Selective Estrogen Receptor Modulator (particularly acolbifene) in order to decrease the risk of breast and uterine cancer normally present in postmenopausal women and to prevent bone loss, fat accumulation and diabetes type 2. Said medicament is also suitable for treating and/or reducing the likelihood of acquiring vaginal diseases or problems in postmenopausal women, wherein the vaginal diseases are selected from the group of diseases consisting of vaginal dryness, vulvo-vaginal dryness, vaginal pruritus, vaginal atrophy, atrophic vaginitis, dyspareunia, vaginal bleeding at sexual activity, sexual dysfunction, loss of libido, loss of compactness of collagen fibers of the vaginal wall, and low muscularis thickness of the vaginal wall.
Patent NZ-602060-A (NZ)
Title: Cable sealing device, cable termination and attaching device
Inventor: KEMPENEERS DIRK
IPC: H02G15/013
Filed: 2011-01-18
Abstract: The present application relates to a cable sealing device for sealing a passage of a cable, to a cable termination provided with the cable sealing device and to an attaching device securable to a cable for supporting an installaltion of the cable sealing device on the cable. The cable sealing device is simply mountable on a cable providing an attaching part and reliably securable on the cable in its circumferential and longitudinal directions. The cable sealing device (10) comprises a sealing part (11) providing a passageway with an inner seal (14) through which a cable (2) is sealingly guidable, and an outer seal (15) arranged on an outer circumference of the sealing part (11). The cable sealing device (10) is characterized by a fixation part (12) adapted to be mountable on an attaching part (4) securable to the cable (2) and providing accessible outer positive locking faces (5, 6) extending in circumferential and longitudinal direction of the cable (2), wherein the fixation part (12) provides inner circumferential and axial abutment faces adapted to co-operate with the outer positive locking faces (5, 6) so as to provide therebetween a positive locking in circumferential and longitudinal direction. The fixation part (12) has first securing means (18) for co-operating with second securing means (19) provided with the sealing part (11) to secure the sealing part (11) in circumferential and longitudinal direction against the fixation part (12).
Patent NZ-604040-A (NZ)
Title: The use of inhibitors of bruton’s tyrosine kinase (btk)
Inventor: HEDRICK ERIC
IPC: C07D487/04
Filed: 2011-06-03
Abstract: Disclosed is the use of (R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (ibrutinib / PCI-32765) (an inhibitor of Bruton’s tyrosine kinase (Btk)) for the manufacture of a medicament for the treatment of mantle cell lymphoma in an individual who has already received at least one prior therapy for mantle cell lymphoma, wherein the medicament is suitable for oral administration once per day of a dose of about 420 mg to about 840 mg. Also disclosed it the use of ibrutinib for the manufacture of a medicament for the treatment of relapsed or refractory chronic lymphocytic leukemia or relapsed or refractory small lymphocytic leukemia in an individual, wherein the medicament is suitable for oral administration once per day of a dose of about 420 mg to about 840 mg, and wherein the medicament optionally further comprises an additional cancer treatment regimen comprising bendamustine, bortezomib, CAL-101, chlorambucil, cyclophosphamide, dexamethasone, docetaxel, doxorubicin, endostatin, everolimus, etoposide, fludarabine, fostamatinib, hydroxydaunorubicin, ibritumomab, ifosphamide, lenalidomide, mesalazine, ofatumumab, paclitaxel, pentostatin, prednisone, rituximab, temsirolimus, thalidomide, tositumomab, vincristine, or a combination thereof, such as rituximab, fludarabine and cyclophosphamide, or rituximab, cyclophosphamide, hydroxdaunorubicin, vincristine and prednisone.
Patent NZ-606378-A (NZ)
Title: Interior fitting for a protective helmet, in particular for forestry workers
Inventor: PFANNER ANTON
IPC: A42B3/14
Filed: 2011-07-12
Abstract: A protective helmet (30) is described, with a helmet shell (36) and with an interior fitting subassembly which comprises at least one supporting cage (42), a head band (44) and a neck band. Three supporting arms (54, 55, Fig:7 56) serve to fasten the subassembly to the helmet shell with a spacing. A clearance (60) is thus provided between the interior fitting subassembly. The supporting arms conduct a force acting on the helmet to elastically deform the helmet shell to improve the shock absorption capability.
Patent NZ-613066-A (NZ)
Title: A sealing arrangement for a solar collector enclosure
Inventor: REARDON JOSEPH
IPC: F28F9/00
Filed: 2011-12-22
Abstract: A sealant channel arrangement for forming a seal between first and second bodies, suitable for use in a solar collector is disclosed. The arrangement has complementary interface surfaces includes an open channel 6.098 formed in the interface surface of the first body. A sealant injection aperture 6.096 in the form of a through hole accessible from the opposite side from the first interface surface is provided. When the two bodies are assembled, the interface surface 6.048 of the second body forms a cover over the channel into which a sealant is administered through the sealant injection aperture. A purge point 6.100 is arranged to be visible when the two components are assembled.
Patent NZ-615466-A (NZ)
Title: Methods for preparing naphthyridines
Inventor: FLYNN BERNARD LUKE
IPC: C07D471/04
Filed: 2012-05-11
Abstract: The present disclosure provides methods of synthesizing substituted 1,8-naphthyridine compounds of formula (1) and intermediates thereto. The present disclosure also provides intermediates useful in the synthesis of compounds of formula (1). In one embodiment the compound of formula (1) is 6-(2,3-dihydro-1H-inden-2-ylamino) 1-ethyl-3-(morpholin-4-ylcarbonyl)-1,8-naphthyridin-4(1H)-one.